This documentary explores the ethical complexities and human costs of the pharmaceutical industry, focusing on two distinct cases where drug companies prioritized profit over patient safety. In Nigeria, a clinical trial for a new antibiotic was conducted on children without proper consent or ethical oversight, leading to tragic consequences. Meanwhile, in South Korea, patients suffering from leukemia are forced to protest against the high cost of a life-saving drug, highlighting the struggle for access to essential medicine. Through these stories, the film examines the power dynamics between global corporations and vulnerable populations, raising critical questions about the responsibility of the medical community and the ethics of drug development.